KORU Medical Systems Announces First Quarter 2026 Results
KORU Medical Systems reported financial results for the first quarter of 2026, with net revenues of $11.8 million, reflecting growth in their patient-centric infusion solutions. The company confirmed its guidance for the full year 2026.
MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2026. The Company also reiterated guidance for the full year 2026. Recent Highlights First quarter 2026 net revenues of $11.8 million grew